Designed specifically for oncology fellows, this half-day, CE-certified program seeks to educate future oncology practitioners about the application of the NCCN Guidelines, the importance of communicating with patients and caregivers about difficult and sensitive topics, and preparing for entry into the oncology workforce.
This program will provide expert insights on the current recommendations of care for patients with breast cancer and include the latest clinical research updates to assist clinicians in formulating breast cancer management strategies.

This program features presentations and interactive discussions highlighting the treatment options and supportive care for a variety of hematologic malignancies.

This program includes educational sessions and clinical scenarios focused on the rapidly evolving area of biomarker testing in oncology.
Designed specifically for oncology fellows, this half-day, CE-certified program seeks to educate future oncology practitioners about the application of the NCCN Guidelines, evidence-based treatment principles for the management of significant cancer types, the implementation of supportive care in oncology, and recommendations for professional career development.

The NCCN 2023 Annual Conference includes educational sessions that highlight significant updates and key issues for select NCCN Guidelines®, new and emerging therapies, controversies in oncology care, issues affecting oncology care, and strategies to address barriers to practice.

This program will provide expert insights on the current recommendations of care for patients with breast cancer and include the latest clinical research updates to assist clinicians in formulating breast cancer management strategies.

The management of cancer is constantly evolving through the introduction of new advances related to cancer treatment and supportive care. This program will provide hematology/oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

The NCCN 2022 Annual Congress: Hematologic Malignancies™ will focus on updates to the NCCN Guidelines®, new, emerging and novel therapeutic agents, advances in cancer care, and the practical management of patients with hematologic malignancies, as well as re-vaccination of patients with hematologic malignancies and hematopoietic growth factors.

Individualizing cancer treatment based upon biomarker testing is a rapidly evolving area in oncology.

Pages

Subscribe to RSS - Live Course